This inventor holds 2 USPTO granted patents. Top assignees: The University of Arizona, Astex Pharmaceutials, Inc., Astex Pharmaceuticals, Inc.. Active years: 2013-2015.
Company Filing History:
2 out of 1,053 
1 out of 1 
1 out of 11 Years Active: 2013-2015
Title: James Welsh: Innovator in Protein Kinase Inhibitors
Introduction
James Welsh is a notable inventor based in Oro Valley, Arizona. He has made significant contributions to the field of medicinal chemistry, particularly in the development of protein kinase inhibitors. With a total of two patents to his name, his work focuses on addressing protein kinase-mediated diseases, including cancer.
Latest Patents
James Welsh's latest patents include innovative compounds that serve as protein kinase inhibitors. These compounds are designed to treat various diseases and conditions mediated by protein kinases. The first patent discloses compounds with specific structures, including stereoisomers, prodrugs, and pharmaceutically acceptable salts. The second patent also focuses on substituted tricyclic compounds with similar utility in treating protein kinase-mediated diseases. Both patents detail compositions containing these compounds and methods for their use.
Career Highlights
Throughout his career, James Welsh has worked with esteemed organizations such as the University of Arizona and Astex Pharmaceuticals, Inc. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
James has collaborated with notable colleagues, including Laurence H. Hurley and Daruka Mahadevan. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
James Welsh is a prominent figure in the field of protein kinase inhibitors, with a focus on developing innovative solutions for serious medical conditions. His contributions continue to influence the landscape of medicinal chemistry and cancer treatment.